With 18 Months of Market Squeeze to Go, Genomics Shops Should Weather the Doldrums (Hint: Don t Consolidate) | GenomeWeb

SAN FRANCISCO, June 21 - Biotech companies will likely wait out a sour market climate by hunkering down and hibernating rather than consolidating either as a target or as an acquirer, according to a panel of biotech finance experts.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.